Malaria in Uganda: Challenges to control on the long road to elimination. I. Epidemiology and current control efforts

Acta Tropica

Volumn 121, Issue 3, 2012, Pages 184-195

  Yeka, Adoke ^a   Gasasira, Anne ^a   Mpimbaza, Arthur ^a   Achan, Jane ^b   Nankabirwa, Joaniter ^b   Nsobya, Sam ^b   Staedke, Sarah G ^c   Donnelly, Martin J ^d   Wabwire Mangen, Fred ^e   Talisuna, Ambrose ^a   Dorsey, Grant ^f   Kamya, Moses R ^b   Rosenthal, Philip J ^f  

^a INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^b MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^e MAKERERE UNIVERSITY   (Uganda)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Artemisinin based combination therapy; Indoor residual spraying; Insecticide treated nets; Intermittent preventive therapy; Malaria; Uganda

Indexed keywords

AMODIAQUINE PLUS ARTESUNATE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ; ARTESUNATE; CHLOROQUINE; COTRIMOXAZOLE; INSECTICIDE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE;

DISEASE PREVALENCE; DISEASE TRANSMISSION; EPIDEMIOLOGY; INSECTICIDE; MALARIA; MORTALITY; MOSQUITO;

ARTICLE; BED NET; DEMOGRAPHY; DISEASE CARRIER; DISEASE SEVERITY; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG EFFICACY; ENDEMIC DISEASE; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; INJECTION SITE STERILE ABSCESS; MALARIA; MALARIA CONTROL; MORTALITY; NERVE PARALYSIS; PLASMODIUM FALCIPARUM; PLASMODIUM MALARIAE; PLASMODIUM OVALE; PLASMODIUM VIVAX; PREVALENCE; UGANDA;

ANIMALS; ANTIMALARIALS; COMMUNICABLE DISEASE CONTROL; DELIVERY OF HEALTH CARE; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE; HUMANS; INSECT VECTORS; INSECTICIDE-TREATED BEDNETS; INSECTICIDES; MALARIA; MOSQUITO CONTROL; PLASMODIUM; PREVALENCE; UGANDA;

UGANDA;

EID: 84857656541     PISSN: 0001706X     EISSN: 18736254     Source Type: Journal    
DOI: 10.1016/j.actatropica.2011.03.004     Document Type: Article

References (56)

1. Aceng J.R., Byarugaba J.S., Tumwine J.K. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. BMJ 2005, 330:334.
2. Achan J., Byarugaba J., Barennes H., Tumwine J.K. Rectal versus intravenous quinine for the treatment of childhood cerebral malaria in Kampala, Uganda: a randomized, double-blind clinical trial. Clin. Infect. Dis. 2007, 45:1446-1452.
3. Achan J., Tibenderana J.K., Kyabayinze D., Wabwire Mangen F., Kamya M.R., Dorsey G., D'Alessandro U., Rosenthal P.J., Talisuna A.O. Effectiveness of quinine versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children: randomised trial. BMJ 2009, 339:b2763.
4. Arinaitwe E., Sandison T.G., Wanzira H., Kakuru A., Homsy J., Kalamya J., Kamya M.R., Vora N., Greenhouse B., Rosenthal P.J., Tappero J., Dorsey G. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in young Ugandan children. Clin. Infect. Dis. 2009, 49:1629-1637.
5. Beier J.C., Keating J., Githure J.I., Macdonald M.B., Impoinvil D.E., Novak R.J. Integrated vector management for malaria control. Malar. J. 2008, 7(Suppl. 1):S4.
6. Bhattarai A., Ali A.S., Kachur S.P., Martensson A., Abbas A.K., Khatib R., Al-Mafazy A.W., Ramsan M., Rotllant G., Gerstenmaier J.F., Molteni F., Abdulla S., Montgomery S.M., Kaneko A., Bjorkman A. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med. 2007, 4:e309.
7. Bimenya G.S., Harabulema M., Okot J.P., Francis O., Lugemwa M., Okwi A.L. Plasma levels of DDT/DDE and liver function in malaria control personnel 6 months after indoor residual spraying with DDT in northern Uganda, 2008. S. Afr. Med. J. 2010, 100:118-121.
8. Breman J.G. The ears of the hippopotamus: manifestations, determinants, and estimates of the malaria burden. Am. J. Trop. Med. Hyg. 2001, 64(suppl):1-11.
9. Bukirwa H., Yau V., Kigozi R., Filler S., Quick L., Lugemwa M., Dissanayake G., Kamya M., Wabwire-Mangen F., Dorsey G. Assessing the impact of indoor residual spraying on malaria morbidity using a sentinel site surveillance system in Western Uganda. Am. J. Trop. Med. Hyg. 2009, 81:611-614.
10. Bukirwa H., Yeka A., Kamya M.R., Talisuna A., Banek K., Bakyaita N., Rwakimari J.B., Rosenthal P.J., Wabwire-Mangen F., Dorsey G., Staedke S.G. Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda. PLoS Clin. Trials 2006, 1:e7.
11. Clark T.D., Njama-Meya D., Nzarubara B., Maiteki-Sebuguzi C., Greenhouse B., Staedke S.G., Kamya M.R., Dorsey G., Rosenthal P.J. Incidence of malaria and efficacy of combination antimalarial therapies over 4 years in an urban cohort of Ugandan children. PLoS One 2010, 5:e11759.
12. Dondorp A., Nosten F., Stepniewska K., Day N., White N. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 2005, 366:717-725.
13. Dondorp A.M., Fanello C.I., Hendriksen I.C., Gomes E., Seni A., Chhaganlal K.D., Bojang K., Olaosebikan R., Anunobi N., Maitland K., Kivaya E., Agbenyega T., Nguah S.B., Evans J., Gesase S., Kahabuka C., Mtove G., Nadjm B., Deen J., Mwanga-Amumpaire J., Nansumba M., Karema C., Umulisa N., Uwimana A., Mokuolu O.A., Adedoyin O.T., Johnson W.B., Tshefu A.K., Onyamboko M.A., Sakulthaew T., Ngum W.P., Silamut K., Stepniewska K., Woodrow C.J., Bethell D., Wills B., Oneko M., Peto T.E., von Seidlein L., Day N.P., White N.J. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial. Lancet 2010, 376:1647-1657.
14. Donnelly M.J., Corbel V., Weetman D., Wilding C.S., Williamson M.S., Black W.C. Does kdr genotype predict insecticide-resistance phenotype in mosquitoes?. Trends Parasitol. 2009, 25:213-219.
15. Dorsey G., Kamya M.R., Ndeezi G., Babirye J.N., Phares C.R., Olson J.E., Katabira E.T., Rosenthal P.J. Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. Am. J. Trop. Med. Hyg. 2000, 62:686-692.
16. Dorsey G., Kamya M.R., Singh A., Rosenthal P.J. Polymorphisms in the Plasmodium falciparum pfcrt and pfmdr-1 genes and clinical response to chloroquine in Kampala, Uganda. J. Infect. Dis. 2001, 183:1417-1420.
17. Dorsey G., Njama D., Kamya M.R., Cattamanchi A., Kyabayinze D., Staedke S.G., Gasasira A., Rosenthal P.J. Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial. Lancet 2002, 360:2031-2038.
18. Dorsey G., Staedke S., Clark T.D., Njama-Meya D., Nzarubara B., Maiteki-Sebuguzi C., Dokomajilar C., Kamya M.R., Rosenthal P.J. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. JAMA 2007, 297:2210-2219.
19. Feachem R.G., Phillips A.A., Targett G.A., Snow R.W. Call to action: priorities for malaria elimination. Lancet 2010, 376:1517-1521.
20. Francis D., Nsobya S.L., Talisuna A., Yeka A., Kamya M.R., Machekano R., Dokomajilar C., Rosenthal P.J., Dorsey G. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J. Infect. Dis. 2006, 193:978-986.
21. Gasasira A.F., Kamya M.R., Ochong E.O., Vora N., Achan J., Charlebois E., Ruel T., Kateera F., Meya D.N., Havlir D., Rosenthal P.J., Dorsey G. Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance. Malar. J. 2010, 9:177.
22. Greenwood B.M., Bojang K., Whitty C.J., Targett T.A. Malaria. Lancet 2005, 365:1487-1498.
23. Jensen T.P., Bukirwa H., Njama-Meya D., Francis D., Kamya M.R., Rosenthal P.J., Dorsey G. Use of the slide positivity rate to estimate changes in malaria incidence in a cohort of Ugandan children. Malar. J. 2009, 8:213.
24. Kamya M.R., Dorsey G., Gasasira A., Ndeezi G., Babirye J.N., Staedke S.G., Rosenthal P.J. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Trans. R. Soc. Trop. Med. Hyg. 2001, 95:50-55.
25. Kamya M.R., Gasasira A.F., Achan J., Mebrahtu T., Ruel T., Kekitiinwa A., Charlebois E.D., Rosenthal P.J., Havlir D., Dorsey G. Effects of trimethoprim-sulfamethoxazole and insecticide-treated bednets on malaria among HIV-infected Ugandan children. AIDS 2007, 21:2059-2066.
26. Kamya M.R., Yeka A., Bukirwa H., Lugemwa M., Rwakimari J.B., Staedke S.G., Talisuna A.O., Greenhouse B., Nosten F., Rosenthal P.J., Wabwire-Mangen F., Dorsey G. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment of malaria: a randomized trial. PLoS Clin. Trials 2007, 2:e20.
27. Kengeya-Kayondo J.F., Seeley J.A., Kajura-Bajenja E., Kabunga E., Mubiru E., Sembajja F., Mulder D.W. Recognition, treatment seeking behaviour and perception of cause of malaria among rural women in Uganda. Acta Trop. 1994, 58:267-273.
28. Morgan J.C., Irving H., Okedi L.M., Steven A., Wondji C.S. Pyrethroid resistance in an Anopheles funestus population from Uganda. PLoS One 2010, 5:e11872.
29. Nankabirwa J., Cundill B., Clarke S., Kabatereine N., Rosenthal P.J., Dorsey G., Brooker S., Staedke S.G. Efficacy, safety, and tolerability of three regimens for prevention of malaria: a randomized, placebo-controlled trial in Ugandan school children. PLoS One 2010, 5:e13438.
30. Ndyomugyenyi R., Magnussen P. Trends in malaria-attributable morbidity and mortality among young children admitted to Ugandan hospitals, for the period 1990-2001. Ann. Trop. Med. Parasitol. 2004, 98:315-327.
31. Nshakira N., Kristensen M., Ssali F., Whyte S.R. Appropriate treatment of malaria? Use of antimalarial drugs for children's fevers in district medical units, drug shops and homes in eastern Uganda. Trop. Med. Int. Health 2002, 7:309-316.
32. Nsobya S.L., Kiggundu M., Nanyunja S., Joloba M., Greenhouse B., Rosenthal P.J. In vitro sensitivities of Plasmodium falciparum to different antimalarial drugs in Uganda. Antimicrob. Agents Chemother. 2010, 54:1200-1206.
33. O'Meara W.P., Bejon P., Mwangi T.W., Okiro E.A., Peshu N., Snow R.W., Newton C.R., Marsh K. Effect of a fall in malaria transmission on morbidity and mortality in Kilifi Kenya. Lancet 2008, 372:1555-1562.
34. O'Meara W.P., Mangeni J.N., Steketee R., Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect. Dis. 2010, 10:545-555.
35. Okello P.E., Van Bortel W., Byaruhanga A.M., Correwyn A., Roelants P., Talisuna A., D'Alessandro U., Coosemans M. Variation in malaria transmission intensity in seven sites throughout Uganda. Am. J. Trop. Med. Hyg. 2006, 75:219-225.
36. President's Malaria Initiative, 2010. President's Malaria Initiative Uganda Malaria Operational Plan for FY 2010.
37. Ramphul U., Boase T., Bass C., Okedi L.M., Donnelly M.J., Muller P. Insecticide resistance and its association with target-site mutations in natural populations of Anopheles gambiae from eastern Uganda. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:1121-1126.
38. Rowe A.K., Kachur S.P., Yoon S.S., Lynch M., Slutsker L., Steketee R.W. Caution is required when using health facility-based data to evaluate the health impact of malaria control efforts in Africa. Malar. J. 2009, 8:209.
39. Rubaihayo J., Tukesiga E., Abaasa A. Reduced susceptibility to pyrethroid insecticide treated nets by the malaria vector Anopheles gambiae s.l. in western Uganda. Malar. J. 2008, 7:92.
40. Snow R.W., Craig M., Deichmann U., Marsh K. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. Bull. World Health Organ. 1999, 77:624-640.
41. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
42. Staedke S.G., Kamya M.R., Dorsey G., Gasasira A., Ndeezi G., Charlebois E.D., Rosenthal P.J. Amodiaquine, sulfadoxine/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 2001, 358:368-374.
43. Staedke S.G., Mpimbaza A., Kamya M.R., Nzarubara B.K., Dorsey G., Rosenthal P.J. Combination treatments for uncomplicated falciparum malaria in Kampala, Uganda: randomised clinical trial. Lancet 2004, 364:1950-1957.
44. Tatem A.J., Smith D.L., Gething P.W., Kabaria C.W., Snow R.W., Hay S.I. Ranking of elimination feasibility between malaria-endemic countries. Lancet 2010, 376:1579-1591.
45. Uganda Bureau of Statistics, 2007. Uganda Demographic and Health Survey 2006.
46. Uganda Bureau of Statistics, 2010. Uganda Malaria Indicator Survey 2009.
47. Uganda Ministry of Health, 2005. Uganda Malaria Control Strategic Plan 2005/6-2009/10.
48. Uganda Ministry of Health, 2008. Service Provision Assessment Survey 2007.
49. Verhaeghen K., Bortel W.V., Roelants P., Okello P.E., Talisuna A., Coosemans M. Spatio-temporal patterns in kdr frequency in permethrin and DDT resistant Anopheles gambiae s.s. from Uganda. Am. J. Trop. Med. Hyg. 2010, 82:566-573.
50. Verhaeghen K., Van Bortel W., Roelants P., Backeljau T., Coosemans M. Detection of the East and West African kdr mutation in Anopheles gambiae and Anopheles arabiensis from Uganda using a new assay based on FRET/Melt curve analysis. Malar. J. 2006, 5:16.
51. Vulule J.M., Beach R.F., Atieli F.K., McAllister J.C., Brogdon W.G., Roberts J.M., Mwangi R.W., Hawley W.A. Elevated oxidase and esterase levels associated with permethrin tolerance in Anopheles gambiae from Kenyan villages using permethrin-impregnated nets. Med. Vet. Entomol. 1999, 13:239-244.
52. World Health Organization, 2008. World Malaria Report. World Health Organization, Geneva.
53. World Health Organization, 2010. Guidelines for the Treatment of Malaria. World Health Organization, Geneva.
54. Yeka A., Banek K., Bakyaita N., Staedke S.G., Kamya M.R., Talisuna A., Kironde F., Nsobya S.L., Kilian A., Slater M., Reingold A., Rosenthal P.J., Wabwire-Mangen F., Dorsey G. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. 2005, 2:e190.
55. Yeka A., Dorsey G., Kamya M.R., Talisuna A., Lugemwa M., Rwakimari J.B., Staedke S.G., Rosenthal P.J., Wabwire-Mangen F., Bukirwa H. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda. PLoS ONE 2008, 3:e2390.
56. Zurovac D., Tibenderana J.K., Nankabirwa J., Ssekitooleko J., Njogu J.N., Rwakimari J.B., Meek S., Talisuna A., Snow R.W. Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malar. J. 2008, 7:181.